Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$98.98 - $115.74 $4 Million - $4.68 Million
-40,400 Reduced 24.63%
123,600 $14.3 Million
Q2 2023

Aug 14, 2023

BUY
$96.34 - $112.38 $8.21 Million - $9.57 Million
85,200 Added 108.12%
164,000 $16.9 Million
Q1 2023

May 12, 2023

SELL
$107.32 - $113.5 $7.69 Million - $8.14 Million
-71,700 Reduced 47.64%
78,800 $8.6 Million
Q4 2022

Feb 13, 2023

BUY
$62.39 - $113.8 $9.39 Million - $17.1 Million
150,500 New
150,500 $17.1 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.